A de novo lineage switch from B-cell acute lymphoblastic leukemia to acute myelocytic leukemia: A case report
Ashok C. Shende
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorAnn L. Zaslav
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorArlene Redner
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorVincent R. Bonagura
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorLynda Hatam
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorCarole Paley
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorPhilip Lanzkowsky
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorAshok C. Shende
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorAnn L. Zaslav
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorArlene Redner
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorVincent R. Bonagura
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorLynda Hatam
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorCarole Paley
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this authorPhilip Lanzkowsky
Divisions of Pediatric Hematology/Oncology, Human Genetics, and Pediatric Allergy/Immunology and Department of Pediatrics of the Schneider Children's Hospital, Long Island Jewish Medical Center, New Hyde Park, New York; Long Island Campus for the Albert Einstein College of Medicine, Bronx, New York
Search for more papers by this author
References
- 1 Patte C, Philip T, Rodary C, Bernard A, Zucker JM, Bernard JL, Robert A, Rialland X, Beng-Lemoine E, Demeoeq F, Bayle C, Lemerle J: Improved survival rate in children with Stage III and IV B-cell non-Hodgkin's lymphoma and leukemia using multiagent chemotherapy. Results of a study of 114 children for the French Pediatric Oncology Society. J Clin Oncol 4: 1219, 1986.
- 2 Sartori PCE, Taylor MH, Stevens MCG, Darbyshire PJ: Treatment of childhood acute myeloid leukemia using the BFM-83 protocol. Med Pediatr Oncol 21: 8, 1993.
- 3 Smith MA, Rubenstein L, Underleider RS: Therapy related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks. Med Pediatr Oncol 23: 86, 1994.
- 4 Groupe Francais de cytogénétique Hématologique (GFCH): Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo and/or radiotherapy: Prognostic significance of karyotype and preceding myelodysplastic syndrome. Leukemia 8: 87, 1994.
Citing Literature
